December 2015 A guest blog by Jeremy Waletzky, MD. Every year since 2003, NIDA has honored a young career scientist with the Society for Neuroscience Jacob P. Waletzky Memorial Award for Innovative Research in Drug Addiction and Alcoholism. This award would not be possible without the generosity of the Waletzky Family, who in memory of their son, wanted to recognize research contributions in the area of drug addiction or alcoholism, and the nervous system. Read More.
November 2015 The FDA announced its approval of the NARCAN Nasal Spray, an intranasal naloxone formula that can immediately restore normal breathing in a person overdosing on prescription opioids or heroin and thus save their life. Read More.
November 2015 Can the addictiveness of cigarettes be minimized by reducing their nicotine content? This idea was first proposed as a public health measure two decades ago, but when the Food and Drug Administration (FDA) argued the case before the Supreme Court in 2000, they were not granted the authority. Read More.
September 2015 The teen years are the period of highest risk for substance use and for the development of other behavioral disorders, and they are also a period when the brain is changing dramatically. A study of this scope will yield an unprecedented amount of detailed information. Read More.
September 2015 Recent research now suggests that bees may be preferentially drawn to foods laced with pesticides as a result of reward mechanisms. It is a fascinating lesson in how knowledge gleaned from one area of science—in this case addiction science—can inform our understanding of a global ecological crisis. Read More.
July 2015 Three weeks ago I had the opportunity to testify before the Senate on cannabidiol, or CBD—one of the main active ingredients in the marijuana plant, and a compound around which there is a growing amount of interest from the public as well as the scientific and medical communities. Read More.
July 2015 Great progress has been made in reducing the number of new HIV infections and transforming the disease into a manageable and livable condition, but we still have some way to go to achieve an AIDS-free world. Injection drug use is still creating new, local epidemics, and the ways substance use disorders and HIV are intertwined often receive insufficient attention. Read More.
June 2015 NIDA’s Advisory Council periodically reviews the various programs and Divisions within the Institute to ensure they best reflect NIDA’s capacities and mission. At our May 2015 Council meeting, an Advisory Council workgroup presented a series of recommendations related to the scientific areas currently led by the Division of Clinical Neuroscience and Behavioral Research (DCNBR). Read More.
June 2015 When I was five or six years old, my grandfather—my mother’s father—died of what I was always told was complications of heart disease. It was not until much later that I learned the real reason for his death. Read More.
May 2015 One of the fastest-spreading recorded U.S. outbreaks of HIV since the inception of the epidemic is now occurring in southeastern Indiana, and it is being driven by injection drug use—specifically, abuse of the opioid painkiller Opana (oxymorphone). Read More.